Company news: Amgen's (AMGN) quarterly earnings marginally miss analysts’ forecasts

Amgen (AMGN) reported Q2 FY2024 earnings of $4.97 per share (versus $5.00 per share in Q2 FY2023), slightly missing analysts’ consensus estimate of $4.98 per share.

The company’s quarterly revenues amounted to $8.388 bln (+20.1% y/y), beating analysts’ consensus estimate of $8.346 bln.

The company also issued narrowed guidance for FY2024, seeing EPS of $19.10-20.10 versus its previous guidance of $19.00-20.20 and analysts’ consensus estimate of $19.50, and revenues of $32.8-33.8 bln versus its previous guidance of $32.5-33.8 bln and analysts’ consensus estimate of $33.07 bln.

AMGN fell to $315.89 (-3.97%) in pre-market trading.